The Discounted Cash Flow (DCF) valuation of Arcturus Therapeutics Holdings Inc (ARCT) is (77.12) USD. With the latest stock price at 13.78 USD, the upside of Arcturus Therapeutics Holdings Inc based on DCF is -659.6%.
Based on the latest price of 13.78 USD and our DCF valuation, Arcturus Therapeutics Holdings Inc (ARCT) is a sell. selling ARCT stocks now will result in a potential gain of 659.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.6% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (411.97) - (41.59) | (77.12) |
| Upside | -3089.6% - -401.8% | -659.6% |